Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Oral Paclitaxel Plus ICI Maintenance in Advanced sqNSCLC and ES-SCLC
NCT07744698Phase 4Recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Jul 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 4 trial of paclitaxel oral solution in squamous cell carcinoma of the lung (SCCL), small cell lung cancer (SCLC), sponsored by Anhui Provincial Tumor Hospital. Started Jul 2026; status: recruiting.
02
Drugs
paclitaxel oral solution
03
Conditions
squamous cell carcinoma of the lung (SCCL)small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT07744698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07744698.